Inpart
PrivateLast Round
Growth Equity
Jul 1, 2021
Total Funding Raised
$70M
Company Overview
Inpart is a software company that provides a cloud-based partnering platform for the life sciences industry to manage biopharma collaborations, deal-making, and alliance management.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inpart Comparables
Compare Inpart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wellspring | 83% | |
| Inteum Company, LLC | 76% | |
| Halo | 74% |
For institutional investors. Book with your work email.
Inpart Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 1, 2021 | ||||
| VC Round | Oct 3, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inpart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Carlyle Group | Growth Equity |
| NextStage AM | Growth Equity, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Grew 19% QoQ, from 149 to 178 employees.
- Nov 27, 2023
Grew 32% QoQ, from 130 to 171 employees.
For institutional investors. Book with your work email.
Inpart Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inpart's valuation, stock price, and market status.
Is Inpart a public or private company?
Inpart is a private company.
What is the current stock price of Inpart?
Inpart is a private company, so its shares have no public market price. Caplight tracks Inpart's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inpart worth (valuation)?
Valuation information for Inpart is not publicly available.
Can I buy Inpart stock?
Inpart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inpart's last funding round?
Inpart's most recent funding round was Growth Equity on July 1, 2021.
Who are the main investors in Inpart?
Key investors in Inpart include The Carlyle Group, NextStage AM.
Will Inpart IPO soon?
No public IPO plans have been announced for Inpart.
How can I track Inpart secondary market activity?
Caplight tracks bids, offers, and trades in Inpart's shares on secondary markets.